BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Federal Trade Commission
US Department of Justice
Mallinckrodt
AstraZeneca
Queensland Health
Julphar
Teva
Cerilliant
Moodys

Generated: January 22, 2018

DrugPatentWatch Database Preview

MEPERIDINE AND ATROPINE SULFATE Drug Profile

« Back to Dashboard

When do Meperidine And Atropine Sulfate patents expire, and when can generic versions of Meperidine And Atropine Sulfate launch?

Meperidine And Atropine Sulfate is a drug marketed by Wyeth Ayerst and is included in one NDA.

The generic ingredient in MEPERIDINE AND ATROPINE SULFATE is atropine sulfate; meperidine hydrochloride. There are twenty-three drug master file entries for this compound. Additional details are available on the atropine sulfate; meperidine hydrochloride profile page.
Summary for MEPERIDINE AND ATROPINE SULFATE
Drug patent expirations by year for MEPERIDINE AND ATROPINE SULFATE

US Patents and Regulatory Information for MEPERIDINE AND ATROPINE SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst MEPERIDINE AND ATROPINE SULFATE atropine sulfate; meperidine hydrochloride INJECTABLE;INJECTION 085121-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wyeth Ayerst MEPERIDINE AND ATROPINE SULFATE atropine sulfate; meperidine hydrochloride INJECTABLE;INJECTION 085121-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wyeth Ayerst MEPERIDINE AND ATROPINE SULFATE atropine sulfate; meperidine hydrochloride INJECTABLE;INJECTION 085121-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Baxter
Merck
Deloitte
UBS
Moodys
Fuji
Cerilliant
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot